|
Post by joeypotsandpans on Oct 26, 2018 13:25:45 GMT -5
On track to close with a higher weekly low, would have needed to take out last weeks low of 1.57...with a deficit of 43M shares would have been a tall order to try to take out but would very much welcome the effort as it would be met with wanting hands Biotechs in general are holding very well today vs. overall broader market...enjoy your weekends!
|
|
|
Post by joeypotsandpans on Oct 22, 2018 13:29:01 GMT -5
I haven’t posted this info for a while because the rate paid has be hanging around 5.25%. Today the rate slipped to 5.125% but none of my shares have been returned. Dropped to 5.00% this morning. Fyi, Interactive currently shows: Symbol: MNKD Availability: 100'000 Exchanges: NASDAQ
|
|
|
Post by joeypotsandpans on Oct 18, 2018 15:47:51 GMT -5
MNKD Nasdaq Real time volume, 4,351,066 shares. MNKD Nasdaq summary volume, 7,807,164 shares MNKD $2.05. +0.12. +6.21% www.nasdaq.com/symbol/mnkd/real-timeresistance here $2.05 the 11/16 swing low. through here, 3.20/3.30 the Sanofi swing low. I'd say that's a very nice looking MACD crossover above the zero line young lady (not to mention a close above the 200d, nice support at the 50d which is back in rising mode...stars are aligning)
|
|
|
Post by joeypotsandpans on Oct 18, 2018 14:15:44 GMT -5
Jumped up after about 2 day flag. I'm surprised it's being sold back down, but it's MNKD. What should I expect? I feel like it will recover on a bigger move as accumulation seems to happening. Considering the Russell, SPX, and the biotech indices are all getting hammered I'd say it's behaving (putting the Carter Worth hat on lol) "relatively" very well, for the most part only green symbol I'm seeing
|
|
|
Post by joeypotsandpans on Oct 17, 2018 16:04:27 GMT -5
Just goes to show what a negative impact that train wreck of a partnership had on MNKD. 3+ years blown. Nova, stop looking in the rear view, that's history, Hamburg and Brown, et al will get their Kharma... nos incipere!!!
|
|
|
Post by joeypotsandpans on Oct 17, 2018 15:58:56 GMT -5
Good publicity because they can't hide or dismiss the true benefits of Afrezza, I love this whole thing as it will wake up the FDA to the benefits that all those taking already know. Part of the process, opening doors and opportunities...let's get that FDA conversation started Mike STAT!! ....The next evolution, open up those diabetic COPD airways with Afrezza+ compound, a twofer!!
|
|
|
Post by joeypotsandpans on Oct 16, 2018 15:23:42 GMT -5
|
|
|
Post by joeypotsandpans on Oct 11, 2018 14:37:43 GMT -5
|
|
|
Post by joeypotsandpans on Oct 11, 2018 13:55:14 GMT -5
The UTHR PUT should remain strong support, the s/p at the top of the breakaway gap is exactly $1.51 (today's low), held nicely as that is the price point that allows both those that missed buying at that level another opportunity to enter/add to positions as well as swing traders to buy confidently at that price. Those of you who bought today have carpe diem More likely what you are seeing at this point is a fight over the $1.50 options than anything to do with UTHR. Seriously I doubt that the minute open interest expiring tomorrow is responsible, lol: Option Chain for MannKind Corporation (MNKD) Calls Last Chg Bid Ask Vol Open Int Root Strike Puts Last Chg Bid Ask Vol Open Int October 2018 Oct 05, 2018 0.20 0 0 MNKD 1.5 Oct 05, 2018 0.01 0 92 Oct 12, 2018 0.10 -0.15 0.06 0.15 volume: 31 open interest 4 MNKD 1.5 Oct 12, 2018 0.03 0.02 0.01 0.03 volume: 148 open interest 259Oct 19, 2018 0.18 -0.09 0.13 0.17 55 160 MNKD 1.5 Oct 19, 2018 0.11 0.07 0.06 0.12 4 693 Oct 26, 2018 0.22 -0.08 0.14 0.21 4 3 MNKD 1.5 Oct 26, 2018 0.06 0.10 0.17 0 103 More likely our baby is getting thrown out with the bath water in the biotech and Russell indices as the 200 day MA's are getting violated...MNKD is actually behaving very well relatively speaking
|
|
|
Post by joeypotsandpans on Oct 11, 2018 12:55:08 GMT -5
The UTHR PUT should remain strong support, the s/p at the top of the breakaway gap is exactly $1.51 (today's low), held nicely as that is the price point that allows both those that missed buying at that level another opportunity to enter/add to positions as well as swing traders to buy confidently at that price. Those of you who bought today have carpe diem
|
|
|
Post by joeypotsandpans on Oct 5, 2018 13:29:39 GMT -5
This is horrible correct? It does not endorse Afrezza as the Standard of Care as we are all hoping for. It does state the following that is key when a patient is not in compliance and inquires about Afrezza: The report suggests that a patient’s medication-taking and self-management behavior (adherence) be specifically considered as part of the decision cycle, ensuring a good match between patient and care plan. Inconsistent medication-taking behavior affects almost half of people with diabetes, which leads to suboptimal blood glucose control and increased CVD risk.This is key in the insurance part of the equation...the changes/updates are opening doors regarding taking the patient's compliance into consideration. In essence it is instructing physicians to be more receptive of the individual patients when it comes to listening to wants and needs with life style and compliance.
|
|
|
Post by joeypotsandpans on Oct 4, 2018 4:41:01 GMT -5
His latest: seekingalpha.com/article/4209761-mannkind-better-r-and-d-company-full-service-pharma-companyMK's response: Michael Kovacocy • 3rd Capital Markets Macro and Micro; Capital Sourcing; Bitcoin and Cryptocurrencies OTC and Trading Advisory; Media Contributor 2h MNKD - I read an article where a certain person who has myopically focused on Afrezza, suddenly sees an R&D company and the need to hive off Afrezza on the cheap...You just don’t stop, do ya?... The smart thing for management to do is to ramp Afrezza sales and make it a winner now that money is coming in from places that this myopic writer never talked of. Make Afrezza a winner and bury these nuisances. Then if you do sell much later, you are selling a winner and the hacks can’t buy themselves a dinner. hashtag#MNKD For anyone that attended the shareholder's meeting, this was addressed back then in May by Mike as he acknowledged exactly what MK states, that Afrezza is the flagship of the company and the future backbone of the company. As an aside, rumor has it that Spiro has recently started accumulating shares again now that he is confident MNKD has secured a runway as far as the eyes can see for continuing their manufacturing of his Afrezza. I guess Spiro is just one of those sponges I mentioned soaking up/absorbing some of those "musical shares"
|
|
|
Post by joeypotsandpans on Oct 3, 2018 12:45:51 GMT -5
Watching volume, looking for any indication more volume will be coming in. 386,789 shares traded real time in an hour and 15 mins. The top of this four day trading wedge is $1.90. If price can get there, it would be nice. www.nasdaq.com/symbol/mnkd/real-timeIn September 2018, Deerfield converted approximately $10.5 million principal amount of Deerfield Notes into an aggregate of 5,749,500 shares of the Company’s common stock at a weighted-average conversion price of $1.83 per share Read more: mnkd.proboards.com/thread/10512/new-8k-filed-09-26#ixzz5StJOiRu5Sponges are out soaking in more shares, shaping up nicely towards the close, price action/volume, here at resistance coincidentally at the DF conversion price area
|
|
|
Post by joeypotsandpans on Oct 2, 2018 18:15:58 GMT -5
MNKD Nasdaq real time volume, 1,709,624 shares. MNKD Nasdaq summary volume, 2,756,485 shares. MNKD $1.68. - 0.09. -5.08% www.nasdaq.com/symbol/mnkdIt seems Europe is unimpressed. Kendall presentation. cantor Fitz didn't help today. Mike C presentation. "Musical shares", more chairs are getting removed while the music plays. The much advertised and "hoped for" dilution that you continue to hear about over the last year will not be what was anticipated as Mike mentioned.
|
|
|
Post by joeypotsandpans on Sept 25, 2018 13:31:16 GMT -5
next hard resistance to have price touch is $2.05. the test this morning was a test of $1.80 the old resistance now the new support. let's see if some volume comes in in this afternoon session. 1,461,111 shares traded realtime with 2 hours left to go. www.nasdaq.com/symbol/mnkd/real-timeAdding the 20d has crossed nicely over the 50 day, and the MACD has also crossed back and turned up...SI thru 9/15 due out in about 90+ min.😉
|
|